Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. purchased 12,500 shares of the firm’s stock in a transaction dated Monday, April 24th. The shares were acquired at an average cost of $3.06 per share, with a total value of $38,250.00. Following the completion of the purchase, the insider now directly […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. acquired 12,500 shares of the stock in a transaction on Monday, April 24th. The shares were bought at an average price of $3.06 per share, with a total value of $38,250.00. Following the purchase, the insider now directly owns 1,310,200 shares of […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. purchased 15,000 shares of the business’s stock in a transaction dated Monday, April 17th. The shares were purchased at an average price of $2.96 per share, with a total value of $44,400.00. Following the purchase, the insider now directly owns 1,282,700 shares […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. bought 15,000 shares of the company’s stock in a transaction that occurred on Monday, April 17th. The stock was purchased at an average price of $2.96 per share, with a total value of $44,400.00. Following the transaction, the insider now directly owns […]